Current Challenges and Opportunities in Treating Glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current Challenges and Opportunities in Treating Glioblastoma

Published:2018-04-18 Issue:3 Volume:70 Page:412-445
ISSN:0031-6997
Container-title:Pharmacological Reviews
language:en
Short-container-title:Pharmacol Rev

Author:

Shergalis Andrea,Bankhead Armand,Luesakul Urarika,Muangsin Nongnuj,Neamati Nouri

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference266 articles.

1. Recent progress in cancer thermal therapy using gold nanoparticles;Abadeer;J Phys Chem C,2016

2. Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases;Abate-Shen;Cancer Res,2003

3. Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux

4. Phase II trial of dovitinib in recurrent glioblastoma;Ahluwalia;J Clin Oncol,2015

5. miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients;Akers;J Neurooncol,2015

Cited by 605 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapy;Biomaterials;2024-12

2. GBM immunotherapy: Exploring molecular and clinical frontiers;Life Sciences;2024-11

3. BOC targets SMO to regulate the Hedgehog pathway and promote proliferation, migration, and invasion of glioma cells;Brain Research Bulletin;2024-10

4. Biophysical translational paradigm of polymeric nanoparticle: Embarked advancement to brain tumor therapy;Biomedicine & Pharmacotherapy;2024-10

5. Doxorubicin-Loaded Ultrasmall Gold Nanoparticles (1.5 nm) for Brain Tumor Therapy and Assessment of Their Biodistribution;ACS Applied Bio Materials;2024-09-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3